Fidelity Investments’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Fidelity Investments’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$234M	Buy	9,045,481 +8,806,603	+3,687%	+$226M	0.01%	790
2025 Q4	$5.5M	Buy	+238,878	New	+$4.15M	﹤0.01%	2255
2021 Q2	–	Sell	-5,333	Closed	-$810K	–	4492
2021 Q1	$810K	Hold	5,333	–	–	﹤0.01%	2616
2020 Q4	$1.67M	Buy	+5,333	New	+$1.98M	﹤0.01%	2438

Other funds holding DMRA

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments's DMRA Position: Q1 2026 in Review

Fidelity Investments increased its Damora Therapeutics, Inc. Ordinary Shares (DMRA) stake by 3,687% in Q1 2026, buying an estimated $226M and bringing the position to 9,045,481 shares worth $234M. The position accounts for 0.01% of the portfolio, ranked #790.

Fidelity Investments first reported a position in DMRA in Q4 2020 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

Fidelity Investments held 9,045,481 shares of Damora Therapeutics, Inc. Ordinary Shares worth $234M as of Q1 2026.
Fidelity Investments bought 8,806,603 Damora Therapeutics, Inc. Ordinary Shares shares in Q1 2026, an estimated $226M.
Damora Therapeutics, Inc. Ordinary Shares made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #790 holding.
Fidelity Investments first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and has held it in 4 quarters since.
65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.